Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Rousseau

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
The Journal of Biological Chemistry|February 5, 2026
Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's diseaseGrigoria Tsaka, Aida Montserrat Pagès, Cristiano Brás De Sousa, et al.
Cell Death and Differentiation|November 9, 2021
Bcl-xL acts as an inhibitor of IP<sub>3</sub>R channels, thereby antagonizing Ca<sup>2+</sup>-driven apoptosisNicolas Rosa, Hristina Ivanova, Larry E Wagner, et al.
Molecular Cancer Therapeutics|November 18, 2020
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor GrowthShauni Lien Geeraerts, Kim Rosalie Kampen, Gianmarco Rinaldi, et al.
Protein Engineering, Design & Selection : PEDS|May 14, 2020
Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4VFilip Claes, Stanislav Rudyak, Angela S Laird, et al.
Nature Communications|June 7, 2020
Reverse engineering synthetic antiviral amyloidsEmiel Michiels, Kenny Roose, Rodrigo Gallardo, et al.
Nature Communications|June 13, 2023
Author Correction: Reverse engineering synthetic antiviral amyloidsEmiel Michiels, Kenny Roose, Rodrigo Gallardo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2023
Exploiting the intrinsic misfolding propensity of the KRAS oncoproteinKobe Janssen, Filip Claes, Dido Van de Velde, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDietmar Rudolf Thal, Alicja Ronisz, Simona Ospitalieri, et al.
Cancer Cell|April 20, 2013
Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signalingCorentin Herbert, Ulrich Schieborr, Krishna Saxena, et al.
Cancer Cell|August 2, 2016
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor SignalingCorentin Herbert, Ulrich Schieborr, Krishna Saxena, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
The Journal of Biological Chemistry|February 5, 2026
Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's diseaseGrigoria Tsaka, Aida Montserrat Pagès, Cristiano Brás De Sousa, et al.
Cell Death and Differentiation|November 9, 2021
Bcl-xL acts as an inhibitor of IP<sub>3</sub>R channels, thereby antagonizing Ca<sup>2+</sup>-driven apoptosisNicolas Rosa, Hristina Ivanova, Larry E Wagner, et al.
Molecular Cancer Therapeutics|November 18, 2020
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor GrowthShauni Lien Geeraerts, Kim Rosalie Kampen, Gianmarco Rinaldi, et al.
Protein Engineering, Design & Selection : PEDS|May 14, 2020
Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4VFilip Claes, Stanislav Rudyak, Angela S Laird, et al.
Nature Communications|June 7, 2020
Reverse engineering synthetic antiviral amyloidsEmiel Michiels, Kenny Roose, Rodrigo Gallardo, et al.
Nature Communications|June 13, 2023
Author Correction: Reverse engineering synthetic antiviral amyloidsEmiel Michiels, Kenny Roose, Rodrigo Gallardo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2023
Exploiting the intrinsic misfolding propensity of the KRAS oncoproteinKobe Janssen, Filip Claes, Dido Van de Velde, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDietmar Rudolf Thal, Alicja Ronisz, Simona Ospitalieri, et al.
Cancer Cell|April 20, 2013
Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signalingCorentin Herbert, Ulrich Schieborr, Krishna Saxena, et al.
Cancer Cell|August 2, 2016
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor SignalingCorentin Herbert, Ulrich Schieborr, Krishna Saxena, et al.
Pageof 21